Rising Biosciences, Inc. Propels Q2 Revenues to Nearly $350,000 Due to Exceptional Growth of Oxi Thy

Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall announced significant revenue growth to nearly $350,000 in Q2 as sales and reception of the company's Oxi Thyme have escalated dramatically. "The activity over the last three months has been incredible", said Hall. "We have already outgrown our original bottling plant and are in the process of building a second bottling facility in South Florida. Currently, we are operating in 14 states, servicing 74 regions from Anchorage, AK to Key West, FL, with more going on line each week." Oxi Thyme has introduced a proprietary system designed to sanitize and disinfect varying facilities in the current challenging environment, quickly and cost ef

Recent Posts


  • Facebook Social Icon